Description
Use: 2 OZ
Rebound & Restore GLP-1 Facial Skin. The first treatment developed for facial changes due to rapid weight loss.
- Breakthrough formulation for GLP-1 facial skin changes
- Patent pending XOSM™ Technology
- Plastic surgeon developed
Directions: Apply liberally to cleansed skin twice per day after your serum of choice. Visible results in 4 weeks and optimal results in 12 with twice-daily use. During the day, use a Daily Prevention sunscreen as the last step in your regimen. In the PM, apply a repair creme suited for your skin type. Make sure to allow your skin to fully absorb any Retinols prior to applying.
VOL.U.LIFT™: the first treatment for GLP-1 skin changes.
VOL.U.LIFT™ GLP-1 4D Skin Rebound Complex is a revolutionary topical treatment that improves the appearance of facial skin in 4D: deflation, deep wrinkles, dehydration and density. VOL.U.LIFT™ GLP-1 4D Skin Rebound Complex is a firming face cream designed with next generation hyaluronic acid, collagen fragments, bakuchiol and amino acids with lipofilling results. The complex of potent actives in our skin tightening crème improves skin impacted by GLP-1 induced facial volume loss and skin texture decline by addressing the appearance of lost volume, sagging, crepey skin texture, dehydration and wrinkles.
What’s the technology behind the VOL.U.LIFT™ innovation?
VOL.U.LIFT™ harnesses next generation ingredients combined with our proprietary, XOSM™ Technology. Patent-pending XOSM™ Technology boosts formula performance while protecting and nourishing skin’s barrier with antioxidants, ectoin, vitamin C and astaxanthin-rich micro-algae. VOL.U.LIFT™ performance is supercharged by HA Silanol, a next generation hyaluronic acid combined with silicium to improve hydration, plumping the skin to restore the appearance of volume. In addition, a non-essential amino acid, L-ornithine, visibly plumps skin, improving the appearance of sunken, deflated skin and promoting a fuller, younger-looking face. The combination of powerful actives specifically targets loss of facial volume to effectively address GLP-1 induced skin changes.
